Prosensa B.V., BioSpring, Institute of Myology, Leiden University Medical Center, Newcastle University musculoskeletal news

Prosensa said the Consortium for Products Across Europe in Duchenne Muscular Dystrophy (SCOPE-DMD) received a €6 million ($8 million) award from the EU's Seventh Framework Program (FP7) to support an ...